Disseminated Mycobacterium bovis after intravesicular bacillus calmette-Gu rin treatments for bladder cancer.
Elkabani
M
M
Department of Medicine, Division of Infectious and Tropical Diseases University of South Florida College of Medicine, Tampa, USA.
Greene
J N
JN
Vincent
A L
AL
VanHook
S
S
Sandin
R L
RL
D000283:Administration, Intravesical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000368:Aged; D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D002417:Cattle; D005500:Follow-Up Studies; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D009163:Mycobacterium bovis / Q000302:isolation & purification*; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D011859:Radiography; D012008:Recurrence; D014391:Tuberculosis, Miliary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014397:Tuberculosis, Pulmonary / Q000150:complications; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000628:therapy
D000305:Adrenal Cortex Hormones; D000995:Antitubercular Agents; D001500:BCG Vaccine